about
S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy.Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimizationAccumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas.Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.Influence of various cytokines on adhesion and migration of the colorectal adenocarcinoma cell line HRT-18.Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study.Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.RANK expression as a prognostic and predictive marker in breast cancer.CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsiesMutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial
P50
Q30319781-E782C12E-493B-41E7-BC50-FC36BD8EC515Q36467712-3B3DFC20-D6F3-45B1-92FE-2730BF1421F2Q36603235-0F5BCD3A-E75A-4DED-801E-42AF4F50B98FQ38801167-35D53980-7E6C-4075-8CC2-622B06A0702CQ40438906-C9E8B610-F508-4F4A-BB34-49D5B44EA03EQ40914660-5DE9C110-F856-48AC-A76D-08312083F1DBQ41698029-0033D955-0016-45D8-B709-99085DC7C5A3Q42315543-07BD8D96-61A1-4C3F-9717-1C43C8EB6D33Q47719898-E3777638-7539-4C2B-8AD5-AEF4D2D3B216Q51022930-57537B90-31AE-4047-A4F2-264FC9D2E069Q52877576-91931829-4055-4B39-92F9-DA330BBB2309Q53303491-9E470375-105C-4237-B1C6-7054C8A25F60Q84291898-0B51B242-FE34-45EB-B16E-29D77974A886Q93064583-DEAD3FCA-F810-4E16-B66B-802B2961F340
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wolfgang D Schmitt
@ast
Wolfgang D Schmitt
@en
Wolfgang D Schmitt
@es
Wolfgang D Schmitt
@nl
Wolfgang D Schmitt
@sl
type
label
Wolfgang D Schmitt
@ast
Wolfgang D Schmitt
@en
Wolfgang D Schmitt
@es
Wolfgang D Schmitt
@nl
Wolfgang D Schmitt
@sl
prefLabel
Wolfgang D Schmitt
@ast
Wolfgang D Schmitt
@en
Wolfgang D Schmitt
@es
Wolfgang D Schmitt
@nl
Wolfgang D Schmitt
@sl
P106
P21
P31
P496
0000-0002-7870-138X